Statistics about Health, Pharma & Medtech in United States
Statistics
- Rallybio operating profit 2020-2023
- Decibel Therapeutics, Inc. total assets 2020-2022
- Rani Therapeutics Holdings net cash 2020-2023
- Decibel Therapeutics, Inc. total equity 2019-2022
- Oragenics Inc total equity 2019-2023
- Otonomy total assets 2017-2021
- Elutia operating profit 2019-2023
- Elutia total assets 2019-2023
- Rockwell Medical gross profit 2019-2023
- Ayala Pharmaceuticals operating profit 2019-2022
- Aquestive Therapeutics total assets 2019-2023
- Avenir Wellness Solutions gross profit 2019-2023
- Marimed Inc. total equity 2014-2018
- Marinus Pharmaceuticals total equity 2019-2023
- Relmada Therapeutics, Inc. revenue 2012-2013
- Odonate Therapeutics, Inc. operating profit 2017-2020
- Avenir Wellness Solutions total equity 2019-2023
- Oncocyte operating profit 2019-2023
- Ocuphire Pharma, Inc. operating profit 2019-2023
- Avenir Wellness Solutions liabilities 2019-2023
- Avenir Wellness Solutions operating profit 2019-2023
- Avenir Wellness Solutions revenue 2019-2023
- Nurix Therapeutics revenue 2019-2023
- Avenir Wellness Solutions net income 2014-2019
- Rockwell Medical revenue 2019-2023
- Ocugen operating profit 2019-2023
- Relay Therapeutics liabilities 2019-2023
- Avenir Wellness Solutions net cash 2019-2023
- Regulus Therapeutics liabilities 2019-2023
- Avid Bioservices net cash 2019-2023
- Avid Bioservices total equity 2019-2023
- Regen Biopharma liabilities 2019-2023
- Avenir Wellness Solutions total assets 2019-2023
- Avid Bioservices total assets 2019-2023
- Avid Bioservices liabilities 2019-2023
- Avid Bioservices gross profit 2019-2023
- Avid Bioservices operating profit 2019-2023
- Aprea Therapeutics operating profit 2021-2023
- Aprea Therapeutics net income 2019-2023
- Avid Bioservices revenue 2019-2023
- Oncocyte gross profit 2020-2023
- Ocugen liabilities 2019-2023
- Medicinova total equity 2019-2023
- Dmk Pharmaceuticals revenue 2018-2022
- Avidity Biosciences net income 2019-2023
- Dyne Therapeutics net income 2019-2023
- Odonate Therapeutics, Inc. total assets 2017-2020
- Dyne Therapeutics operating profit 2019-2023
- Regulus Therapeutics net cash 2019-2023
- Oncocyte total assets 2019-2023
- Ocuphire Pharma, Inc. total assets 2019-2023
- Regen Biopharma net cash 2019-2023
- Ocugen total assets 2019-2023
- Avidity Biosciences total assets 2019-2023
- Avidity Biosciences total equity 2019-2023
- Odonate Therapeutics, Inc. net cash 2017-2020
- Avidity Biosciences net cash 2019-2023
- Avidity Biosciences liabilities 2019-2023
- Avidity Biosciences revenue 2019-2023
- Marimed Inc. total assets 2019-2023
- Oncocyte net cash 2019-2023
- Avidity Biosciences operating profit 2019-2023
- Renovorx liabilities 2020-2023
- Ocuphire Pharma, Inc. net cash 2019-2023
- Ocugen net cash 2019-2023
- Dermata Therapeutics total equity 2019-2023
- Dermata Therapeutics liabilities 2020-2023
- Dermata Therapeutics operating profit 2020-2023
- Dermata Therapeutics total assets 2020-2023
- Dermata Therapeutics net cash 2020-2023
- Odonate Therapeutics, Inc. liabilities 2017-2020
- Marinus Pharmaceuticals total assets 2019-2023
- Oncocyte liabilities 2019-2023
- Ocuphire Pharma, Inc. liabilities 2019-2023
- Dmk Pharmaceuticals net income 2018-2019
- Renovorx operating profit 2020-2023
- Dermtech, Inc. gross profit 2019-2023
- Ayala Pharmaceuticals total assets 2019-2022
- Aptevo Therapeutics net income 2019-2023
- Bio-Path Holdings net cash 2019-2023
- Bio-Path Holdings liabilities 2019-2023
- Onconetix, Inc. net cash 2021-2023
- Ayala Pharmaceuticals total equity 2018-2022
- Dermtech, Inc. operating profit 2019-2023
- Onconetix, Inc. net income 2022-2023
- Bio-Path Holdings revenue 2014-2018
- Bio-Path Holdings operating profit 2019-2023
- Bio-Path Holdings net income 2022-2023
- Dermtech, Inc. total assets 2019-2023
- Dermtech, Inc. revenue 2019-2023
- Dermtech, Inc. liabilities 2019-2023
- Aptinyx total equity 2018-2022
- Aptinyx liabilities 2018-2022
- Nurix Therapeutics operating profit 2019-2023
- Aptinyx total assets 2018-2022
- Aptevo Therapeutics revenue 2018-2022
- Aptevo Therapeutics total assets 2019-2023
- Aptinyx net cash 2018-2022
- Aptevo Therapeutics total equity 2019-2023
- Aptevo Therapeutics liabilities 2019-2023